Human dermal MSCs expressing ATP-Binding Cassette member B5 (ABCB5) have shown therapeutic efficacy in clinical trials in chronic skin wounds or recessive dystrophic epidermolysis bullosa. Here, ABCB5 is linked to recessive dystrophic epidermolysis bullosa inversa.